Additional file 1 of Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease

Autor: van Kooten, Harmke A., Ditters, Imke A. M., Hoogeveen-Westerveld, Marianne, Jacobs, Edwin H., van den Hout, Johanna M. P., van Doorn, Pieter A., Pijnappel, W. W. M. Pim, van der Ploeg, Ans T., van der Beek, Nadine A. M. E.
Rok vydání: 2022
DOI: 10.6084/m9.figshare.19112737
Popis: Additional file 1. Table S1-S4 and Figure S1-S3. Table S1 - Residual ��-glucosidase activity. Table S2 - Infusion Associated Reactions (IARs). Table S3 - Scores on the motor domain of the Bayley scales of infant development-II for Patient 1. Table S4 - Standardized infusion protocol. Figure S1 - Anti-recombinant human acid ��-glucosidase (anti-rhGAA) antibody titer course in Experiment 1 and Experiment 2. Figure S2 - Correlation between the age at start of ERT and peak anti-rhGAA antibody titers. Figure S3 - Correlation between residual ��-glucosidase activity and peak anti-rhGAA antibody titers.
Databáze: OpenAIRE